Mechanical ventilation in patients with idiopathic pulmonary fibrosis in Korea: a nationwide cohort study

被引:0
|
作者
Sim, Jae Kyeom [1 ]
Moon, Seok Joo [2 ]
Choi, Juwhan [1 ]
Oh, Jee Youn [1 ]
Lee, Young Seok [1 ]
Min, Kyung Hoon [1 ]
Hur, Gyu Young [1 ]
Lee, Sung Yong [1 ]
Shim, Jae Jeong [1 ,3 ]
机构
[1] Korea Univ, Guro Hosp, Dept Internal Med, Div Pulm Allergy & Crit Care Med,Coll Med, Seoul, South Korea
[2] Korea Univ, Coll Med, Smart Hlth Care Ctr, Guro Hosp, Seoul, South Korea
[3] Korea Univ, Dept Internal Med, Div Pulm Allergy & Crit Care Med, Guro Hosp, 148 Gurodong Ro, Seoul 08308, South Korea
来源
KOREAN JOURNAL OF INTERNAL MEDICINE | 2024年 / 39卷 / 02期
关键词
Idiopathic pulmonary fibrosis; Respiration; artificial; Ventilators; mechanical; Mortality; Hospital mortality; RESPIRATORY-FAILURE; ACUTE EXACERBATION; DIAGNOSIS; OUTCOMES; MORTALITY; DISEASE; UPDATE; ADULTS;
D O I
10.3904/kjim.2023.273
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background/Aims: The prognosis of patients with idiopathic pulmonary fibrosis (IPF) and respiratory failure requiring mechanical ventilation is poor. Therefore, mechanical ventilation is not recommended. Recently, outcomes of mechanical ventilation, including those for patients with IPF, have improved. The aim of this study was to investigate changes in the use of mechanical ventilation in patients with IPF and their outcomes over time. Methods: This retrospective, observational cohort study used data from the National Health Insurance Service database. Patients diagnosed with IPF between January 2011 and December 2019 who were placed on mechanical ventilation were included. We analyzed changes in the use of mechanical ventilation in patients with IPF and their mortality using the Cochran -Armitage trend test. Results: Between 2011 and 2019, 1,227 patients with IPF were placed on mechanical ventilation. The annual number of patients with IPF with and without mechanical ventilation increased over time. However, the ratio was relatively stable at approximately 3.5%. The overall hospital mortality rate was 69.4%. There was no improvement in annual hospital mortality rate. The overall 30 -day mortality rate was 68.7%, which did not change significantly. The overall 90 -day mortality rate was 85.3%. The annual 90 -day mortality rate was decreased from 90.9% in 2011 to 83.1% in 2019 (p = 0.028). Conclusions: Despite improvements in intensive care and ventilator management, the prognosis of patients with IPF receiving mechanical ventilation has not improved significantly.
引用
收藏
页码:295 / 305
页数:13
相关论文
共 50 条
  • [41] INCREASED RISK OF IDIOPATHIC PULMONARY FIBROSIS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A NATIONWIDE POPULATION-BASED STIDY IN KOREA
    Kim, Jihye
    Lee, Changhyun
    Chun, Jaeyoung
    Han, Kyungdo
    Lee, Jooyoung
    Im, Jong Pil
    Kim, Joo Sung
    GASTROENTEROLOGY, 2018, 154 (06) : S609 - S610
  • [42] Smoking status and clinical outcome in idiopathic pulmonary fibrosis: a nationwide study
    Yoon, Hee-Young
    Kim, Hoseob
    Bae, Yoonjong
    Song, Jin Woo
    RESPIRATORY RESEARCH, 2024, 25 (01)
  • [43] Impact of smoking on the development of idiopathic pulmonary fibrosis: results from a nationwide population-based cohort study
    Bae, Won
    Lee, Chang-Hoon
    Lee, Jinwoo
    Kim, Young Whan
    Han, Kyungdo
    Choi, Sun Mi
    THORAX, 2022, 77 (05) : 470 - 476
  • [44] Investigation of clinical predictors of survival in idiopathic pulmonary fibrosis patients: A cohort study in Taiwan
    Tseng, Ching-Min
    Chen, Mei-Yin
    Kao, Chen-Yu
    Tao, Chi-Wei
    JOURNAL OF THE CHINESE MEDICAL ASSOCIATION, 2022, 85 (05) : 578 - 583
  • [45] Pirfenidone vs. nintedanib in patients with idiopathic pulmonary fibrosis: a retrospective cohort study
    Pavo Marijic
    Larissa Schwarzkopf
    Lars Schwettmann
    Thomas Ruhnke
    Franziska Trudzinski
    Michael Kreuter
    Respiratory Research, 22
  • [46] Pirfenidone vs. nintedanib in patients with idiopathic pulmonary fibrosis: a retrospective cohort study
    Marijic, Pavo
    Schwarzkopf, Larissa
    Schwettmann, Lars
    Ruhnke, Thomas
    Trudzinski, Franziska
    Kreuter, Michael
    RESPIRATORY RESEARCH, 2021, 22 (01)
  • [47] Determinants of survival in lung transplantation patients with idiopathic pulmonary fibrosis: a retrospective cohort study
    Tuyls, Sebastiaan
    Verleden, Stijn E.
    Wuyts, Wim A.
    Yserbyt, Jonas
    Vos, Robin
    Verleden, Geert M.
    TRANSPLANT INTERNATIONAL, 2019, 32 (04) : 399 - 409
  • [48] Preclinical idiopathic pulmonary fibrosis (IPF): a retrospective cohort study
    Bando, Tomohiro
    Takei, Reoto
    Fukihara, Jun
    Sasano, Hajime
    Yamano, Yasuhiko
    Yokoyama, Toshiki
    Matsuda, Toshiaki
    Kataoka, Kensuke
    Kimura, Tomoki
    Hatabu, Hiroto
    Fukuoka, Junya
    Johkoh, Takeshi
    Kondoh, Yasuhiro
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [49] Outcomes After Hospitalization in Idiopathic Pulmonary Fibrosis A Cohort Study
    Brown, A. Whitney
    Fischer, Chelsea P.
    Shlobin, Oksana A.
    Buhr, Russell G.
    Ahmad, Shahzad
    Weir, Nargues A.
    Nathan, Steven D.
    CHEST, 2015, 147 (01) : 173 - 179
  • [50] Delayed Access and Survival in Idiopathic Pulmonary Fibrosis A Cohort Study
    Lamas, Daniela J.
    Kawut, Steven M.
    Bagiella, Emilia
    Philip, Nisha
    Arcasoy, Selim M.
    Lederer, David J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 184 (07) : 842 - 847